drawing of magnifying glass on a brain
Biotech

GSK cuts losses on $700M upfront Alzheimer’s collab with Alector

GSK has walked away from a $2.2 billion biobucks neurodegenerative disease pact with Alector that has seen both drugs involved flunk clinical trials.
James Waldron Jul 9, 2026 7:30am
pause halt pause button

FDA halts release of new drug rejection letters

Jul 8, 2026 1:33pm
ArticlePrimaryImagejpg

Can We Outrun Cancer's Evolution? Why We Need a New Approach

Brought to you by BrYet US, Inc.
computer and clinical science AI data

Fate’s CAR-T prospect shows early promise in systemic sclerosis

Jul 9, 2026 10:24am
Exhibition Hall BIO

Biotech revenue plans ‘won’t look as sunny’ after Trump tax bill

Jul 9, 2026 9:28am
Law Legal System Justice Crime concept Mallet Gavel Hammer and Scales on tabl

Prime wins gene editing patent fight with Beam

Jul 8, 2026 11:07am
More News

Satellos’ ‘intriguing’ DMD data raise hopes ahead of key readout

Jul 8, 2026 9:48am

Scipher picks up Chemomab’s liver disease drug via merger

Jul 8, 2026 9:26am
Fierce Healthcare

Leo Cancer Care secures $65M for upright radiotherapy

Jul 8, 2026 8:45am

Fierce Biotech Layoff Tracker 2026: BioCryst, Biogen, & more

Jul 8, 2026 7:30am